Shares of Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) shot up 2.4% on Wednesday . The stock traded as high as €60.10 ($68.30) and last traded at €59.70 ($67.84). 149,308 shares were traded during trading, an increase of 58% from the average session volume of 94,405 shares. The stock had previously closed at €58.30 ($66.25).
Carl Zeiss Meditec Stock Down 2.2%
The firm's 50-day moving average price is €58.60 and its 200 day moving average price is €56.17. The firm has a market cap of $5.30 billion, a P/E ratio of 30.41, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98. The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41.
Carl Zeiss Meditec Company Profile
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Recommended Stories
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
